Alyeska Investment Group, L.P. - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 8 filers reported holding ACCELERON PHARMA INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$17,210,000
+174.3%
100,000
+100.0%
0.21%
+195.8%
Q2 2021$6,275,000
-8.2%
50,000
-0.8%
0.07%
-18.2%
Q1 2021$6,838,000
+144.3%
50,423
-32.8%
0.09%
+319.0%
Q3 2017$2,799,000
+76.8%
75,000
+25.0%
0.02%
+40.0%
Q1 2016$1,583,000
+1.7%
60,000
-14.3%
0.02%
-76.6%
Q3 2013$1,556,00070,0000.06%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2013
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 42,030$3,777,0006.01%
Artal Group S.A. 1,500,000$134,805,0005.70%
GREAT POINT PARTNERS LLC 535,627$48,137,0005.03%
KINGDON CAPITAL MANAGEMENT, L.L.C. 211,038$18,966,0003.47%
Cormorant Asset Management, LP 825,000$74,143,0003.44%
Graticule Asia Macro Advisors LLC 48,700$4,377,0003.20%
Avoro Capital Advisors LLC 860,000$77,288,0002.61%
QVT Financial LP 120,264$10,808,0002.52%
Ikarian Capital, LLC 316,900$28,480,0002.14%
Avidity Partners Management LP 166,000$14,918,0002.06%
View complete list of ACCELERON PHARMA INC shareholders